158 related articles for article (PubMed ID: 36230842)
1. Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018.
Wang J; Lv C; Zhou M; Xu JY; Chen B; Wan Y
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230842
[TBL] [Abstract][Full Text] [Related]
2. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
3. Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.
Wang Z; Yin Y; Wang J; Zhu Y; Li X; Zeng X
Front Oncol; 2021; 11():716741. PubMed ID: 34395291
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysis.
Giri S; Barth P; Costa LJ; Olszewski AJ
J Geriatr Oncol; 2021 Mar; 12(2):256-261. PubMed ID: 32684352
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
6. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database.
Afify AY; Ashry MH
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38775833
[TBL] [Abstract][Full Text] [Related]
7. Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia.
Shrestha R; Giri S; Pathak R; Bhatt VR
World J Clin Oncol; 2016 Aug; 7(4):324-30. PubMed ID: 27579252
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
9. Second primary malignancy among malignant solid tumor survivors aged 85 years and older.
Zhang Z; Liu F; Qu Y; Qiu L; Zhang L; Yang Q
Sci Rep; 2021 Oct; 11(1):19748. PubMed ID: 34611235
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
11. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
Li Z; Wang K; Shi Y; Zhang X; Wen J
Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
[TBL] [Abstract][Full Text] [Related]
12. Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients.
Rosenberg AS; Brunson A; Tuscano J; Jonas BA; Hoeg R; Wun T; Keegan THM
Blood Cancer J; 2021 Jan; 11(1):5. PubMed ID: 33414400
[TBL] [Abstract][Full Text] [Related]
13. Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics.
Razavi P; Rand KA; Cozen W; Chanan-Khan A; Usmani S; Ailawadhi S
Blood Cancer J; 2013 Jun; 3(6):e121. PubMed ID: 23811785
[TBL] [Abstract][Full Text] [Related]
14. Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
Wang J; Du Y; Kang Y
Int J Gynaecol Obstet; 2024 Jun; 165(3):1229-1236. PubMed ID: 38205842
[TBL] [Abstract][Full Text] [Related]
15. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancies after ocular adnexal lymphoma diagnosis.
Loya A; Ramachandran V; Ayaz T; Weng CY
BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
[TBL] [Abstract][Full Text] [Related]
17. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
18. Second primary malignancy in patients with cholangiocarcinoma: a population-based study.
Zhuang L; Yan X; Meng Z
Cancer Manag Res; 2019; 11():1969-1983. PubMed ID: 30881122
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy.
Rock CB; Chipman JJ; Parsons MW; Weil CR; Hutten RJ; Tao R; Tward JD; Shah HR; Hu B; Stephens DM; Gaffney DK
Adv Radiat Oncol; 2022; 7(6):101035. PubMed ID: 36420188
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
